Earnings

In this article CMCSA Comcast reported second-quarter earnings Thursday morning that beat analyst expectations on the top and bottom lines. The company also reported a record of new broadband subscribers for the quarter. Shares were up more than 2% in premarket trading. Here’s what Comcast reported compared to Wall Street’s expectations: Adjusted earnings per share:
0 Comments
In this article MCD McDonald’s on Wednesday reported double-digit U.S. same-store sales growth compared with 2019 levels in its latest quarter, fueled by higher demand for its chicken menu items. Shares of the company were flat in premarket trading. Here’s what the company reported compared with what Wall Street was expecting, based on a survey
0 Comments
In this article GOOGL Alphabet reported Q2 2021 earnings after the bell. The stock rose more than 3% after hours on the strong numbers, which crushed analyst expectations. Here are the results. Earnings per share (EPS): $27.26 vs $19.34 per share, according to Refinitiv estimates. Revenue: $61.88 billion vs $56.16 billion, according to Refinitiv estimates.
0 Comments
Apple CEO Tim Cook attends the Allen & Company Sun Valley Conference on July 08, 2021 in Sun Valley, Idaho. Kevin Dietsch | Getty Images Apple reported earnings after the bell. Here are the results. EPS: $1.30 vs. $1.01 estimated Revenue: $81.4 billion vs. $73.30 billion estimated Wall Street is also watching several other key
0 Comments
In this article INTC Pat Gelsinger Horacio Villalobos | Corbis News | Getty Images Intel shares fell 2% after CEO Pat Gelsinger’s second earnings report at the helm of the American chip giant. Intel reported revenue and earnings per share that beat both the company’s own forecast as well as Wall Street expectations, attributing the
0 Comments
In this article BIIB Aduhelm by Biogen Source: Biogen Biogen‘s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. Biogen upped its revenue guidance for the year, saying it now
0 Comments
In this article SNAP Snap‘s stock rose more than 16% on Thursday after the company reported its second-quarter earnings, beating expectations across the board for earnings, revenue and user growth. Here’s what Snap reported versus Wall Street’s estimates: Adjusted earnings per share: 10 cents vs. 1 cent loss forecast by Refinitiv Revenue: $982 million vs. $846 million
0 Comments